Sanofi/Regeneron unveil more positive data for PCSK9 inhibitor
admin 12th June 2017 Uncategorised 0Sanofi and Regeneron have unveiled new data further backing the safety and efficacy of PCSK9 inhibitor Praluent in lowering cholesterol in patients with diabetes.
More: Sanofi/Regeneron unveil more positive data for PCSK9 inhibitor
Source: News